vimarsana.com

Latest Breaking News On - Pharmaceuticals stock down - Page 22 : vimarsana.com

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Recommendation of "Hold" from Brokerages

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Recommendation of "Hold" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
China
Joshuab-cohen
Gina-mazzariello
Analyst-recommendations-for-amylyx-pharmaceuticals
News-ratings-for-amylyx-pharmaceuticals-daily
Nasdaq
Amylyx-pharmaceuticals
Osaic-holdings-inc
Royal-bank
China-universal-asset-management-co

Jennison Associates LLC Lowers Holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Jennison Associates LLC reduced its position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 7.5% in the fourth quarter, Holdings Channel reports. The firm owned 3,275,922 shares of the company’s stock after selling 266,287 shares during the period. Jennison Associates LLC’s holdings in Apellis Pharmaceuticals were worth $196,097,000 at the end of […]

Pascal-deschatelets
Nur-nicholson
Fiera-capital-corp
Goldman-sachs-group
Jefferies-financial-group
Holdings-channel
Apellis-pharmaceuticals-stock-down
Apellis-pharmaceuticals
Vanguard-group-inc
Quarter-for-apellis-pharmaceuticals
Jpmorgan-chase-co
Charles-schwab-investment-management-inc

Jennison Associates LLC Has $196.10 Million Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Jennison Associates LLC lessened its holdings in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 7.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 3,275,922 shares of the company’s stock after selling 266,287 shares during the period. Jennison Associates LLC owned 2.76% of Apellis Pharmaceuticals […]

United-states
American
Nur-nicholson
Pascal-deschatelets
Raymond-james
Wynnefield-capital-inc
Jefferies-financial-group
Goldman-sachs-group
Apellis-pharmaceuticals
Apellis-pharmaceuticals-stock-down
Quarter-for-apellis-pharmaceuticals
Jpmorgan-chase-co

Longboard Pharmaceuticals' (LBPH) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $60.00 price objective on the stock. LBPH has been the topic of a number of other reports. Guggenheim increased their price objective on […]

Arena-pharmaceuticals-inc
News-ratings-for-longboard-pharmaceuticals-daily
Vanguard-group-inc
Jpmorgan-chase-co
Nasdaq
Longboard-pharmaceuticals-company-profile
Longboard-pharmaceuticals-inc
Blackrock-inc
Polar-capital-holdings-plc
Cantor-fitzgerald
Securities-exchange-commission

11,419 Shares in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Bought by DGS Capital Management LLC

DGS Capital Management LLC purchased a new position in shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,419 shares of the specialty pharmaceutical company’s stock, valued at approximately $60,000. DGS Capital […]

United-states
Eagle-pharmaceuticals-inc
Dgs-capital-management
Blackrock-inc
Eagle-pharmaceuticals
Capital-management
Quarter-for-eagle-pharmaceuticals
News-ratings-for-eagle-pharmaceuticals-daily
Eagle-pharmaceuticals-profile
Exchange-commission
Vanguard-group-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.